Justices Pass On Reviewing MS Drug Arbitration Feud
The U.S. Supreme Court on Monday passed on reviewing a Second Circuit decision refusing to add some $66 million to a $16.6 million arbitral award issued to Acorda Therapeutics in a multiple...To view the full article, register now.
Already a subscriber? Click here to view full article